Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
20.98
+0.08 (0.38%)
Jul 31, 2026, 3:04 PM CST
SHE:002287 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,418 | 2,416 | 2,338 | 2,045 | 2,045 | 1,770 |
Revenue Growth | 1.78% | 3.34% | 14.32% | 0.02% | 15.49% | 19.22% |
Gross Profit Gross Profit Growth | 2,017 | 2,005 | 1,918 | 1,720 | 1,719 | 1,501 |
Operating Income Operating Income Growth | 597.07 | 603.98 | 536.7 | 467.52 | 527.71 | 416.45 |
Net Income Net Income Growth | 667.92 | 648.43 | 582.28 | 581.2 | 472.54 | 715.88 |
Earnings Per Share EPS Growth | 1.21 | 1.19 | 1.10 | 1.10 | 0.89 | 1.35 |
EPS Growth | 14.46% | 8.64% | 0.15% | 23.05% | -34.13% | 77.01% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Medicine Medicine Growth | 2,401 | 2,318 | 2,026 | 2,031 | 1,756 |
Others Others Growth | 14.98 | 19.7 | 19.6 | 14.22 | 14.16 |
Total Total Growth | 2,416 | 2,338 | 2,045 | 2,045 | 1,770 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 2,655 | 3,040 | 2,997 | 2,366 | 2,202 | 1,958 |
Total Debt Total Debt Growth | 807.83 | 929.84 | 1,698 | 1,535 | 1,697 | 1,452 |
Net Cash (Debt) Net Cash Growth | 1,847 | 2,110 | 1,299 | 831.28 | 504.82 | 506.11 |
Net Cash Growth | 33.02% | 62.46% | 56.24% | 64.67% | -0.26% | -18.75% |
Net Cash Per Share Net Cash Per Share Growth | 3.34 | 3.88 | 2.45 | 1.57 | 0.95 | 0.96 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 310.41 | 729.7 | 456.75 | 693.41 | 285.69 | 1,035 |
Capital Expenditures CapEx Growth | -125.06 | -153.08 | -255.44 | -234.81 | -272.4 | -125.57 |
Free Cash Flow Free Cash Flow Growth | 185.35 | 576.63 | 201.31 | 458.59 | 13.29 | 909.35 |
Free Cash Flow Growth | -71.37% | 186.44% | -56.10% | 3350.89% | -98.54% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 83.40% | 83.00% | 82.06% | 84.12% | 84.08% | 84.77% |
Operating Margin | 24.69% | 25.00% | 22.96% | 22.86% | 25.81% | 23.52% |
Pretax Margin | 31.42% | 30.62% | 27.64% | 31.51% | 25.39% | 44.50% |
Profit Margin | 27.62% | 26.84% | 24.91% | 28.42% | 23.11% | 40.43% |
FCF Margin | 7.66% | 23.87% | 8.61% | 22.42% | 0.65% | 51.36% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.380 | 0.410 | 0.380 | 0.480 | 0.390 | 0.590 |
Dividend Per Share Growth | 5.00% | 7.90% | -20.83% | 23.08% | -33.90% | 73.53% |
Dividend Yield | 1.81% | 1.77% | 1.88% | 2.31% | 1.88% | 2.18% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 17.35 | 20.78 | 19.49 | 20.52 | 25.52 | 22.54 |
Forward PE | - | 43.51 | 43.51 | 43.51 | 43.51 | 43.51 |
P/FCF Ratio | 64.17 | 23.37 | 56.36 | 26.00 | 907.60 | 17.74 |
PS Ratio | 4.92 | 5.58 | 4.85 | 5.83 | 5.90 | 9.11 |